NEW YORK, Jan. 30, 2025 /PRNewswire/ -- CurePSP announced the recipients of their Collaborative Approaches to Resources, Education and Support (CARES) grants designed to advance best practices in the ...

NEW YORK, June 3, 2025 /PRNewswire/ -- CurePSP has announced student fellowship recipients, totaling nine projects between the Urso Student Fellowship Grant and the Jim Atwood Neuroscience Student ...

NEW YORK, Sept. 11, 2025 /PRNewswire/ -- CurePSP, the leading research and advocacy nonprofit organization for progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system ...

We at CurePSP extend our heartfelt support to Rev. Jesse L. Jackson, Sr., his family and the entire community of individuals who have been touched by his lifelong pursuit of justice and equity. News ...

NEW YORK, Oct. 5, 2023 /PRNewswire/ -- CurePSP has announced the designation of three new CurePSP Centers of Care, bringing the total to 33 centers across the United States and Canada. Vanderbilt ...

SAN DIEGO, Oct. 4, 2017 /PRNewswire/ -- Dthera Sciences (OTCQB:DTHR), a digital therapeutics company focused on developing innovative digital quality of life therapies for neurodegenerative diseases ...

NEW YORK--(BUSINESS WIRE)--CurePSP, the foundation for prime of life neurodegeneration, has named Lawrence I. Golbe, MD, one of the world’s leading clinical experts in progressive supranuclear palsy ...

NEW YORK, Jan. 20, 2023 /PRNewswire/ -- CurePSP has announced the recipients of the first Collaborative Approaches to Resources, Education and Support (CARES) research grants. The goal of CARES is to ...

TIMONIUM, Md., June 19, 2011 /PRNewswire/ -- An international team of researchers led by Gerard D. Schellenberg, PhD, a member of the CurePSP Genetics Consortium and professor of Pathology and ...

NEW YORK--(BUSINESS WIRE)--CurePSP has awarded a $100,000 grant for a potentially breakthrough study that will employ 3D organoid models that have been shown to produce structures similar to those ...

NEW YORK, Oct. 2, 2020 /PRNewswire/ -- CurePSP has awarded $300,000 in grants to four studies in the closely related diseases progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).